Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.
Cooper LV, Erbeto TB, Danzomo AA, Abdullahi HW, Boateng K, Adamu US, Shuaib F, Modjirom N, Gray EJ, Bandyopadhyay AS, Zipursky S, Okiror SO, Grassly NC, Blake IM. Cooper LV, et al. Among authors: zipursky s. Lancet Infect Dis. 2024 Apr;24(4):427-436. doi: 10.1016/S1473-3099(23)00688-6. Epub 2024 Jan 18. Lancet Infect Dis. 2024. PMID: 38246190 Free article.
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Macklin GR, Peak C, Eisenhawer M, Kurji F, Mach O, Konz J, Gast C, Bachtiar NS, Bandyopadhyay AS, Zipursky S; nOPV2 Working Group. Macklin GR, et al. Among authors: zipursky s. Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A122-A127. doi: 10.1016/j.vaccine.2022.02.050. Epub 2022 Mar 17. Vaccine. 2023. PMID: 35307230 Free PMC article.
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
Martin J, Burns CC, Jorba J, Shulman LM, Macadam A, Klapsa D, Majumdar M, Bullows J, Frolov A, Mate R, Bujaki E, Castro CJ, Bullard K, Konz J, Hawes K, Gauld J, Blake IM, Mercer LD, Kurji F, Voorman A, Diop OM, Oberste MS, Modlin J, Macklin G, Eisenhawer M, Bandyopadhyay AS, Zipursky S. Martin J, et al. Among authors: zipursky s. MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):786-790. doi: 10.15585/mmwr.mm7124a2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35709073 Free article.
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Harutyunyan V, Quddus A, Pallansch M, Zipursky S, Woods D, Ottosen A, Vertefeuille J, Lewis I. Harutyunyan V, et al. Among authors: zipursky s. Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A70-A78. doi: 10.1016/j.vaccine.2022.02.058. Epub 2022 Mar 10. Vaccine. 2023. PMID: 35282924 Free PMC article.
154 results